Docket Number:13A-1070516
Inventor:Nan-Shih Liao
IP Status:Pending
Abstract:
The present invention provides a formulation and method for preparing specific T cells, and a method for fabricating the formulation is also disclosed. The formulation can induce specific T cell responses, and comprises at least a cell population of dendritic killer cells presenting specific antigens.
Fields of Application:
Cancer therapy
Advantages when compared to the existing technologies:
Lower cost than production of genetically engineered T cells
Contact Person:Sue-Ming Chang / 886-2-2787-2600 / name4517@gate.sinica.edu.tw
